Blue Mountains GP Dr Teresa Towpik has spoken out to encourage others to review the research supporting the therapeutic use of cannabis taking into account “observational evidence” from patients and carers.
Dr Towpik was unsuccessful in her attempts to prescribe a medicinal cannabis product for a patient with chronic pain and cautioned that patients trying to access medicinal cannabis may resort to the black and miss out on proper medical management.
State-based rules make it increasingly difficult to access medicinal cannabis with GPs including RACGP President Dr Bastian Seidel calling for a unified system of access.
Read the article here.
In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.
We’re thrilled to announce we have received our export licence from the Drug Control Section of the ODC (Office of Drug Control). We’re firmly on course to continue to lead the way and be the first medicinal cannabis company in Australia to export cannabis flower to the EU since export was legalised in 2018.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.LEARN ABOUT ANTG HERE >